Lorus Therapeutics Inc. (Lorus) is a life sciences company focused on the discovery, research and development of anticancer therapies. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to an... more

UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders... more

Serono is a global biotechnology leader. The Company has seven recombinant products, Rebif®, Gonal-F®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen® and Zorbtive (Luveris® is not approved in the USA). In addition to being the world leader in reproductive health, Serono has strong... more

CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more

Neurogen Corporation (Neurogen) is a drug discovery and development company focusing on new small molecule drugs for the treatment of disorders with unmet medical need, including insomnia, pain, Parkinson’s disease, restless legs syndrome (RLS), anxiety and schizophrenia. Neurogen has... more

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from... more

Corixa (Nasdaq: CRXA) is a developer of immunotherapeutics with a commitment to treating and preventing cancer and infectious diseases by understanding and directing the immune system. On June 30, 2003, Corixa announced that the FDA approved BEXXAR for the treatment of patients with CD20... more

ADVENTRX Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing product candidates primarily for the treatment of cancer and infectious disease. The Company is focused primarily on advancing ANX-530 and ANX-514, which are emulsion... more

Antisoma plc (Antisoma) is a United Kingdom-based biopharmaceutical company, focused on developing products for the treatment of cancer. The Company has a portfolio of drugs in development, including small molecules, antibody-based therapies and a deoxyribonucleic acid (DNA) aptamer.... more

Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a... more

XOMA Ltd. is a biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies. The Company’s lead product candidate is XOMA 052, a high affinity anti-IL-1 beta antibody with the potential to treat multiple inflammatory diseases of large unmet... more

Aastrom Biosciences, Inc. (Aastrom) is a regenerative medicine company engaged in the development of autologous cell products for the repair or regeneration of human tissue. The Company’s tissue repair cell (TRC) technology involves the use of a patient’s own cells to manufacture products... more

Zymogenetics, Inc. is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases. The Company's therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. Its... more

Biocon Limited (Biocon) is engaged in manufacturing biotechnological products in the pharmaceutical through fermentation-based technology, and is also engaged in the formulation business. In the biopharmaceuticals segment, it focuses on the manufacture and marketing of active... more

SuperGen, Inc. is a pharmaceutical company dedicated primarily to the discovery, development and commercialization of therapies to treat patients with cancer. The Company acquires products that were developed by other companies and applies additional developmental effort to expand sales... more

Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovations.

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

Pharmacopeia, Inc. is a clinical development stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics to address medical needs. It has a portfolio of clinical and preclinical candidates under development internally or by partners, including eight... more

ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s lead products, which are in clinical-stage testing, consist of ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an... more

Transition Therapeutics Inc. is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. The Company operates in one business segment being the research and development of therapeutic agents. The Company has two technologies in... more

Bioniche Life Sciences Inc. is a Canadian biopharmaceutical company engaged in the research, development, manufacturing and commercialization of human and animal health products and technologies worldwide. Headquartered in Belleville, Ontario, the Company has offices and manufacturing... more

Accentia BioPharmaceuticals, Inc (Nasdaq:ABPI) is a vertically-integrated specialty biopharmaceutical company, formed by the Hopkins Capital Group, LLC and affiliates to acquire late-stage targeted therapeutics and to use patented delivery technologies to enhance the performance of these... more

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic and cardiovascular, and infectious diseases and cancer. The Company’s principal therapeutic platforms include... more

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases. As of December 31, 2007, the Company had one marketed product and multiple product candidates in clinical development. It markets... more

Antigenics Inc. is a biotechnology company focused on developing technologies and product candidates to treat cancers and infectious diseases, primarily based on immunological approaches. The Company’s principal product candidate is Oncophage (vitespen), a patient-specific therapeutic... more

Vertex Pharmaceuticals Incorporated (Vertex) is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, lead drug candidate, is an oral hepatitis C protease inhibitor and one of the... more

Boston Life Sciences, Inc (NASDAQ: BLSI) is a biotechnology company engaged in the research and development of biopharmaceutical products for the diagnosis and treatment of Central Nervous System disorders. Our energy and focus in this area are reflected in several important initiatives.... more

Protein Design Labs is a leader in the development of humanized antibodies to prevent or treat various disease conditions. PDL currently has antibodies under development for autoimmune and inflammatory conditions, asthma and cancer. PDL holds fundamental patents for its antibody... more

Corautus Genetics Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapy products for the treatment of cardiovascular and vascular disease. Corautus is currently developing and testing a gene therapy product using the Vascular... more

Actelion Ltd is a Swiss biopharmaceutical company that focuses on the discovery and development of treatments to serve unmet medical needs. Its products specialize in conditions related to the endothelium. The Company has three approved drugs on the market. Tracleer, an orally available... more

Genome Therapeutics is a biopharmaceutical company focused on the discovery and development of pharmaceutical and diagnostics products. The Company's first product candidate, Ramoplanin, is in a Phase III clinical trial for the prevention of bloodstream infections caused by... more

Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Our goal is to provide patients and physicians with... more

Protein Polymer Technologies, Inc. is a biotechnology company. The Company is engaged in the research, development and production of bio-active devices to improve medical and surgical outcomes. It produces molecular weight polymers that can be processed into a range of material forms,... more

Valentis is focused on the creation of innovative cardiovascular therapeutics. The Company begins its product development at the stage of a known molecule or protein and applies its expertise in formulation, manufacturing, clinical development and regulatory affairs to create products... more

BioSante Pharmaceuticals, Inc. is a biopharmaceutical company that develops hormone therapy products to treat men and women. The Company is also engaged in the development of its calcium phosphate nanotechnology (CaP), primarily for aesthetic medicine, vaccines and drug delivery. Its... more

Althea Technologies, Inc., based in San Diego, CA, is focused on reducing the time, risk, and overall cost of our partner's drug development efforts. We apply immediate resources, unsurpassed scientific expertise, and a vast knowledge of regulatory affairs to facilitate the progression... more

QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. We currently have four product candidates in clinical development. Our two lead... more

Genaissance is focused on integrating the use of human gene variation into the development of a new generation of DNA-based diagnostic and therapeutic products. The Company markets its HAPÔ Technology, clinical development skills and services to the pharmaceutical, biotechnology and... more

Cytochroma Inc. is a development stage specialty pharmaceutical company focused on the treatment and prevention of disorders related to Vitamin D insufficiency. The Company has a portfolio of therapeutics with lower development risk for the indications of Vitamin D insufficiency and for... more

Indevus Pharmaceuticals, Inc. (Indevus) is a pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company’s products include SANCTURA and SANCTURA XR for overactive bladder (OAB), which it... more

SciClone Pharmaceuticals, Inc. (SciClone ) is a biopharmaceutical company engaged in the development and commercialization of therapeutics to treat life-threatening diseases. The Company has two assets, a biotechnology business focused on developing late-stage products for cancer and... more

AnorMED Inc. is a Canadian biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products for the treatment of a variety of diseases, including cancer, HIV and inflammation. Our strength lies in our medicinal chemistry capabilities that... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

Hemispherx Biopharma, Inc. (Hemispherx) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based chronic disorders. The... more

Nuvelo, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. The Company’s development pipeline includes alfimeprase, a direct-acting fibrinolytic in... more

Neurobiological Technologies, Inc. is a biopharmaceutical company focused on developing first-in-class treatments for central nervous system conditions and other serious unmet medical needs. The Company’s most advanced product candidate, Viprinex, is in Phase III clinical testing as an... more

The Company was originally founded in 1987 with the objective of developing proprietary drug discovery technologies based on naturally occurring plants and organisms. Investment was made in selected target technologies, particularly in the cancer and cardiovascular therapeutic areas. As... more

AVI BioPharma, Inc. (AVI) is a biopharmaceutical company developing therapeutic products principally based on third-generation NeuGene antisense technology. The Company’s principal products in development target life-threatening diseases, including cardiovascular, infectious, and genetic... more

Endovasc, Inc. is a business development company focused on drug development in the areas of cardiovascular and metabolic medicine. The Company’s licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable prostheses (stents)... more

Northwest Biotherapeutics, Inc. is a development-stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that generate and enhance immune system responses to effectively treat cancer. The Company's approach in developing cancer therapies... more